AU8968598A - Bovine footrot treatment and prevention - Google Patents

Bovine footrot treatment and prevention

Info

Publication number
AU8968598A
AU8968598A AU89685/98A AU8968598A AU8968598A AU 8968598 A AU8968598 A AU 8968598A AU 89685/98 A AU89685/98 A AU 89685/98A AU 8968598 A AU8968598 A AU 8968598A AU 8968598 A AU8968598 A AU 8968598A
Authority
AU
Australia
Prior art keywords
prevention
treatment
bovine footrot
footrot
bovine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU89685/98A
Inventor
Douglas W. Morck
Merle E. Olson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University Technologies International Inc
Original Assignee
University Technologies International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Technologies International Inc filed Critical University Technologies International Inc
Publication of AU8968598A publication Critical patent/AU8968598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0216Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/86Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
AU89685/98A 1997-09-08 1998-08-28 Bovine footrot treatment and prevention Abandoned AU8968598A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5816797P 1997-09-08 1997-09-08
US60058167 1997-09-08
US8554098P 1998-05-15 1998-05-15
US60085540 1998-05-15
PCT/CA1998/000823 WO1999012564A1 (en) 1997-09-08 1998-08-28 Bovine footrot treatment and prevention

Publications (1)

Publication Number Publication Date
AU8968598A true AU8968598A (en) 1999-03-29

Family

ID=26737316

Family Applications (1)

Application Number Title Priority Date Filing Date
AU89685/98A Abandoned AU8968598A (en) 1997-09-08 1998-08-28 Bovine footrot treatment and prevention

Country Status (3)

Country Link
AU (1) AU8968598A (en)
CA (1) CA2300958A1 (en)
WO (1) WO1999012564A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241992B1 (en) * 1997-09-08 2001-06-05 University Technologies International, Inc. Bovine footrot treatment and prevention
US6667040B2 (en) 1997-09-08 2003-12-23 University Technologies International, Inc. Bovine footrot treatment and prevention
AU783861B2 (en) * 1999-07-02 2005-12-15 University Of New England, The Control of acidosis
AUPQ137699A0 (en) 1999-07-02 1999-07-22 University Of New England, The Control of acidosis
JP2022533724A (en) * 2019-05-21 2022-07-25 エヴェロ バイオサイエンシズ,インコーポレーテッド Methods and compositions for anaerobic bacterial fermentation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288617A (en) * 1984-10-31 1994-02-22 Commonwealth Scientific And Industrial Research Organization Method of producing an antigenic preparation
WO1992003553A1 (en) * 1990-08-17 1992-03-05 Daratech Pty. Ltd. Footrot vaccine
DE4324859A1 (en) * 1992-07-23 1994-01-27 Lion Corp Oral compsn. for treating periodontal disease - contg. antibody obtd. by immunising animal with surface polysaccharide from pathogenic bacteria

Also Published As

Publication number Publication date
CA2300958A1 (en) 1999-03-18
WO1999012564A1 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
AU8693098A (en) Compositions and methods for treating diabetes
EP0837933A4 (en) Optimized minizymes and miniribozymes and uses thereof
AU1100599A (en) Fraud prevention method and system
AU9790198A (en) Compounds and methods
AU6241698A (en) Tace-like and matrilysin-like polypeptides
AU6902296A (en) Waste treatment and minimization system
AU9781998A (en) Huchordin and uses thereof
AU3227197A (en) Lactoferrin variants and uses thereof
AU4899096A (en) P-heteroatom-substituted phenols and uses thereof
AUPO976597A0 (en) Method and composition (I)
AU2418499A (en) Org-5222 in the treatment of depression
AU5798996A (en) Adnaz, compositions and processes
ZA964862B (en) Optimized minizymes and miniribozymes and uses thereof
AU8695298A (en) Compounds and uses thereof
AU5031398A (en) Gas treatment devices and systems
AU8968598A (en) Bovine footrot treatment and prevention
AU6840898A (en) Cremating method and cremator
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU5188296A (en) Carbopeptoids and carbonucleotoids
AU1645599A (en) Human matrilin-3
AU8155898A (en) Human preprotachykinin b
AU7353598A (en) Implant system
AU8693198A (en) Compounds and uses thereof
AU2708597A (en) An improvement in the treatment of wastes
AU7287798A (en) Compositions and methods for bioremediation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase